Alfuzosin Hydrochloride
- Product NDC
- 70934-306
- 11-digit product format
- 709340306
- Labeler code
- 70934
- Product ID
- 70934-306_d17a80ba-2b1c-abd0-e053-2a95a90a1f83
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alfuzosin Hydrochloride
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA079057
- Marketing category
- ANDA
- Marketing start
- 2019-03-21
- Marketing end
- 0000-00-00
- Substance
- ALFUZOSIN HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70934-306-30 | Alfuzosin Hydrochloride | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70934-306 | ALFUZOSIN HYDROCHLORIDE TABLET, EXTENDED RELEASE [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] | 3 | Legacy NDC, 1 package rows | 20211229_8b256346-9450-54b5-e053-2995a90ae259.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-306-30 | 70934030630 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70934-306-30) | 2019-03-21 | 0000-00-00 | No | No | Current |